Literature DB >> 29605702

Role of the Cortico-Subthalamic Hyperdirect Pathway in Deep Brain Stimulation for the Treatment of Parkinson Disease: A Diffusion Tensor Imaging Study.

Yukun Chen1, Shunnan Ge1, Yang Li1, Nan Li1, Jing Wang1, Xin Wang1, Jiaming Li1, Jiangpeng Jing1, Mingming Su1, Zhaohui Zheng1, Tian Luo1, Chun Qiu1, Xuelian Wang2.   

Abstract

OBJECTIVE: To evaluate the clinical effect of the position of stimulation contacts relative to the hyperdirect pathway (HDP) on the alleviation of motor symptoms in patients with Parkinson disease (PD).
METHODS: A group of 11 patients diagnosed with idiopathic PD were included in this study, and all selected targets were in the subthalamic nucleus (STN). In 1 patient, a single side electrode was implanted because of unilateral symptoms; in all other patients, bilateral electrodes each containing 4 discrete contacts were implanted. Nine contacts were excluded due to adverse reactions caused by stimulation, and thus a total of 75 active contacts were evaluated using the same stimulus parameters. Fiber tractography results were individually processed using StealthViz software before all data were subjected to statistical analysis.
RESULTS: Under the same stimulus parameters, the shortest distance of each contact to the HDP was smaller in group I (n = 45; >50% improvement rate) compared with group II (n = 30; ≤50% improvement rate) (mean, 1.18 ± 0.86 mm vs. 2.14 ± 1.20 mm; t = 3.78; P < 0.05), and the shortest distance had a negative correlation with the improvement of motor symptoms (r = -0.48; P < 0.05).
CONCLUSIONS: Stimulation of the HDP coincided with the improvement of motor symptoms in patients with PD. We propose an improvement of the direct visualization method based on diffusion tensor imaging fiber tractography of the HDP to select the motor part of the STN. Further rigorous clinical trials are needed to verify the value of this method for achieving precise target location and individualized treatment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep brain stimulation; Diffusion tensor imaging; Hyperdirect pathway; Parkinson's disease

Mesh:

Year:  2018        PMID: 29605702     DOI: 10.1016/j.wneu.2018.03.149

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Latency of subthalamic nucleus deep brain stimulation-evoked cortical activity as a potential biomarker for postoperative motor side effects.

Authors:  Zachary T Irwin; Mohammad Z Awad; Christopher L Gonzalez; Arie Nakhmani; J Nicole Bentley; Thomas A Moore; Kenneth G Smithson; Barton L Guthrie; Harrison C Walker
Journal:  Clin Neurophysiol       Date:  2020-03-12       Impact factor: 3.708

2.  A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder.

Authors:  Pankaj Sah; Peter A Silburn; Philip E Mosley; François Windels; John Morris; Terry Coyne; Rodney Marsh; Andrea Giorni; Adith Mohan; Perminder Sachdev; Emily O'Leary; Mark Boschen
Journal:  Transl Psychiatry       Date:  2021-03-29       Impact factor: 6.222

3.  Automated Steerable Path Planning for Deep Brain Stimulation Safeguarding Fiber Tracts and Deep Gray Matter Nuclei.

Authors:  Alice Segato; Valentina Pieri; Alberto Favaro; Marco Riva; Andrea Falini; Elena De Momi; Antonella Castellano
Journal:  Front Robot AI       Date:  2019-08-06

4.  Somatotopic Organization of Hyperdirect Pathway Projections From the Primary Motor Cortex in the Human Brain.

Authors:  Sonia Pujol; Ryan P Cabeen; Jérôme Yelnik; Chantal François; Sara Fernandez Vidal; Carine Karachi; Eric Bardinet; G Rees Cosgrove; Ron Kikinis
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.003

5.  Brain connectivity markers for the identification of effective contacts in subthalamic nucleus deep brain stimulation.

Authors:  Hai Lin; Peng Na; Doudou Zhang; Jiali Liu; Xiaodong Cai; Weiping Li
Journal:  Hum Brain Mapp       Date:  2020-01-17       Impact factor: 5.038

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.